Fitch: Biologics to Play Increasing Role in Global Drug Research

CHICAGO--()--Link to Fitch Ratings' Report: Global Pharmaceutical R&D Pipeline (Advancing Cancer Therapies)

http://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=751631

Biologics will play an increasing role in global drug development as the number of new molecular entities (NMEs) increases, according to a new Fitch Ratings report.

The numbers of NME approvals in 2014 through the end of May were up compared to the prior year five-month period in 2013. The FDA cleared 16 novel medicines for U.S. marketing during the first five months of 2014 compared to 14 in 2013. Interestingly, six biologics were approved in the 2014 period, while only one was approved in the 2013 period.

The full report 'Global Pharmaceutical R&D Pipeline' is available at 'www.fitchratings.com.' The report provides full R&D data for all of the major global pharmaceutical companies.

Additional information is available at 'www.fitchratings.com'.

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

Contacts

Fitch Ratings
Robert Kirby, CFA
Director
+1-312-368-3147
Fitch Ratings, Inc.
70 W. Madison Street
Chicago, IL 60602
or
Frank Orthbandt
+00-44-20-3530-1037
or
Media Relations:
Brian Bertsch, +1-212-908-0549 (New York)
brian.bertsch@fitchratings.com

Contacts

Fitch Ratings
Robert Kirby, CFA
Director
+1-312-368-3147
Fitch Ratings, Inc.
70 W. Madison Street
Chicago, IL 60602
or
Frank Orthbandt
+00-44-20-3530-1037
or
Media Relations:
Brian Bertsch, +1-212-908-0549 (New York)
brian.bertsch@fitchratings.com